6-89146170-T-C
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001010853.3(PM20D2):āc.26T>Cā(p.Val9Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000217 in 1,521,344 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001010853.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PM20D2 | NM_001010853.3 | c.26T>C | p.Val9Ala | missense_variant | 1/7 | ENST00000275072.5 | |
LOC101929004 | XR_942766.4 | n.697A>G | non_coding_transcript_exon_variant | 1/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PM20D2 | ENST00000275072.5 | c.26T>C | p.Val9Ala | missense_variant | 1/7 | 1 | NM_001010853.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 151808Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.0000388 AC: 6AN: 154776Hom.: 0 AF XY: 0.0000344 AC XY: 3AN XY: 87262
GnomAD4 exome AF: 0.0000212 AC: 29AN: 1369536Hom.: 1 Cov.: 31 AF XY: 0.0000252 AC XY: 17AN XY: 674984
GnomAD4 genome AF: 0.0000263 AC: 4AN: 151808Hom.: 1 Cov.: 33 AF XY: 0.0000405 AC XY: 3AN XY: 74132
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 09, 2021 | The c.26T>C (p.V9A) alteration is located in exon 1 (coding exon 1) of the PM20D2 gene. This alteration results from a T to C substitution at nucleotide position 26, causing the valine (V) at amino acid position 9 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at